Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT04528771
What this trial is testing

S-Nitrosylation Therapy of COVID-19

Who this might be right for
SARS-CoV2 InfectionCovid19
James Reynolds
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Post-approval studies (Phase 4)Study completedNCT04869358
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT07126392
What this trial is testing

You and Me Healthy: Test to Treat

Who this might be right for
COVID - 19
Duke University 913
Not applicableStudy completedNCT05676047
What this trial is testing

Cognitive Rehabilitation for Long COVID

Who this might be right for
Long COVID
McMaster University 100
Not applicableWithdrawnNCT04456426
What this trial is testing

Characteristics of Patients With COVID-19 in Meta State, Colombia

Who this might be right for
COVIDSARS-CoV 2SARS Pneumonia+2 more
Hospital Departamental de Villavicencio
Not applicableStudy completedNCT04578509
What this trial is testing

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Assistance Publique - Hôpitaux de Paris 5,197
Not applicableUnknownNCT04916821
What this trial is testing

Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19)

Who this might be right for
SARS-CoV2 Infection
Trabzon Kanuni Education and Research Hospital 45
Not applicableStudy completedNCT04401436
What this trial is testing

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Who this might be right for
Coronavirus Disease 2019
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT07601126
What this trial is testing

Respiratory Pathogen Distribution During and After the COVID-19 Pandemic

Who this might be right for
Viral Respiratory Infection (e.g., Influenza)Bacterial Respiratory Infections
Hisar Intercontinental Hospital 537
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Not applicableUnknownNCT04583306
What this trial is testing

The Salivary Raman COVID-19 Fingerprint

Who this might be right for
Covid19
Fondazione Don Carlo Gnocchi ETS 120
Testing effectiveness (Phase 2)UnknownNCT04341207
What this trial is testing

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients

Who this might be right for
Cancer & COVID 19
Gustave Roussy, Cancer Campus, Grand Paris 1,000
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Testing effectiveness (Phase 2)Study completedNCT04374565
What this trial is testing

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Who this might be right for
Corona Virus InfectionSARS-CoV 2SARS Pneumonia+1 more
University of Virginia 29
Not applicableUnknownNCT05042011
What this trial is testing

Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study

Who this might be right for
mHealthSocial MediaVaccine Hesitancy+1 more
Aga Khan University 80
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Not applicableStudy completedNCT04410432
What this trial is testing

Immune Response and Risk of Serious Infection to SARS-Cov2

Who this might be right for
SARS Cov2, Immune Response
Centre Hospitalier Universitaire Dijon 39
Not applicableLooking for participantsNCT06928506
What this trial is testing

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Who this might be right for
Long COVIDPost COVID-19 ConditionPost Acute Sequelae of COVID-19
University Health Network, Toronto 120
Next Page